title: Cardiopulmonary bypass in the early puerperium: possible new role for aprotinin.
abstract: A case of successful emergency reoperation for mitral valve replacement 2 hours after a cesarean section is reported. The use of aprotinin (Trasylol; Bayer AG, Leverkusen, Germany) greatly simplified the surgical procedure and was in our opinion the most important factor in an uncomplicated outcome.
authors.affiliation: Department of Cardiac Surgery, University Hospital of Wales, Cardiff, United Kingdom.
authors.forename: M
authors.initials: M
authors.lastname: Lamarra
authors.forename: A A
authors.initials: AA
authors.lastname: Azzu
authors.forename: E N
authors.initials: EN
authors.lastname: Kulatilake
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D007611:Aprotinin / Q000008:administration & dosage*; D002315:Cardiopulmonary Bypass; D002585:Cesarean Section; D004630:Emergencies; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008943:Mitral Valve / Q000002:abnormalities / Q000601:surgery; D006473:Postpartum Hemorrhage / Q000188:drug therapy; D049590:Postpartum Period; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011250:Pregnancy Complications, Hematologic / Q000209:etiology / Q000601:surgery; D012086:Reoperation; D013927:Thrombosis / Q000517:prevention & control / Q000601:surgery
chemical_list: D000925:Anticoagulants; D007611:Aprotinin